M

Midwest Children's Health Research Institute | South Office

Research site

(Unclaimed)

Location

4020 Hohensee Drive, Lincoln, Nebraska, United States of America

Site insights

Top conditions

Top treatments

Donepezil Hydrochloride

rLP2086

Lubiprostone

Dextromethorphan

Eszopiclone

HCl

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

4 of 33 total trials

A Study to Learn About How a New Pneumococcal Vaccine Works in Infants

The purpose of this study is to learn about the safety of a new pneumococcal vaccine and how the new pneumococcal vaccine helps to fight against germ...

Enrolling

Pneumococcal Disease

Biological: 15-valent pneumococcal conjugate vaccine (PCV15)

Biological: PG4

A Study to Learn About Variant-Adapted COVID-19 RNA Vaccine Candidate(s) in Healthy Children

The purpose of this clinical trial is to learn about the safety, extent of the side effects, and immune responses of the study vaccine (called varian...

Enrolling

COVID-19

SARS-CoV-2 Virus

Biological: Bivalent BNT162b2 (original/Omicron BA.4/BA.5) 10 microgram dose

Biological: Variant-adapted BNT162b2 (Omicron XBB.1.5) 3 microgram dose

Safety, Tolerability, and Immunogenicity of a 24-Valent Pneumococcal Conjugate Vaccine (VAX-24) in Healthy Infants

The objective of the study is to evaluate the safety and tolerability of 4 injections of VAX-24 (at 3 dose levels) compared to PCV15 in infants at 2,...

Active, not recruiting

Pneumococcal Vaccines

Biological: 0.5 ml dose of 1.1 mcg VAX-24

Biological: 0.5 ml dose of 2.2 mcg VAX-24

Study of the Safety of a 21-valent Pneumococcal Conjugate Vaccine in Healthy Infants From Approximately 2 Months of Age

This study is a Phase 3, randomized, modified double-blind study which aims to document the safety profile of the PCV21 vaccine (investigational pneu...

Enrolling

Pneumococcal Immunization

Biological: Varivax

Biological: M-M-R II vaccine